Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 17

    1.

    Role of glycogen synthase kinase-3 alpha in insulin action in cultured human skeletal muscle cells.

    Ciaraldi TP, Nikoulina SE, Bandukwala RA, Carter L, Henry RR.

    Endocrinology. 2007 Sep;148(9):4393-9. Epub 2007 Jun 14.PMID: 17569761 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue.

    Ciaraldi TP, Oh DK, Christiansen L, Nikoulina SE, Kong AP, Baxi S, Mudaliar S, Henry RR.

    Am J Physiol Endocrinol Metab. 2006 Nov;291(5):E891-8. Epub 2006 Jun 6.PMID: 16757548 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    PYY[3-36] administration decreases the respiratory quotient and reduces adiposity in diet-induced obese mice.

    Adams SH, Lei C, Jodka CM, Nikoulina SE, Hoyt JA, Gedulin B, Mack CM, Kendall ES.

    J Nutr. 2006 Jan;136(1):195-201.PMID: 16365082 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Exenatide (exendin-4) improves insulin sensitivity and {beta}-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight.

    Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, Parkes DG, Young AA.

    Endocrinology. 2005 Apr;146(4):2069-76. Epub 2004 Dec 23.PMID: 15618356 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle.

    Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR.

    Diabetes. 2002 Jul;51(7):2190-8.PMID: 12086949 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Role of glycogen synthase kinase-3 in skeletal muscle insulin resistance in Type 2 diabetes.

    Ciaraldi TP, Nikoulina SE, Henry RR.

    J Diabetes Complications. 2002 Jan-Feb;16(1):69-71. Review. No abstract available. PMID: 11872371 [PubMed - indexed for MEDLINE]Related articles

    7.

    Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation.

    Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR.

    J Clin Endocrinol Metab. 2001 Sep;86(9):4307-14.PMID: 11549666 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle.

    Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti JR Jr, Henry RR.

    Diabetologia. 2001 Apr;44(4):444-52.PMID: 11357475 [PubMed - indexed for MEDLINE]Related articles

    9.

    Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression.

    Park KS, Ciaraldi TP, Carter L, Mudaliar S, Nikoulina SE, Webster NJ, Henry RR.

    Metabolism. 2000 Aug;49(8):962-8.PMID: 10954011 [PubMed - indexed for MEDLINE]Related articles

    10.

    Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.

    Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR.

    Diabetes. 2000 Feb;49(2):263-71.PMID: 10868943 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes.

    Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB.

    J Clin Invest. 1999 Sep;104(6):733-41.PMID: 10491408 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.

    Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR.

    J Clin Endocrinol Metab. 1998 Aug;83(8):2830-5.PMID: 9709955 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects.

    Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR.

    J Clin Endocrinol Metab. 1998 May;83(5):1636-43.PMID: 9589670 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects.

    Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR.

    Diabetes. 1997 Jul;46(7):1230-4.PMID: 9200661 [PubMed - indexed for MEDLINE]Related articles

    15.

    Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.

    Nikoulina SE, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Henry RR.

    Diabetes. 1997 Jun;46(6):1017-24.PMID: 9166674 [PubMed - indexed for MEDLINE]Related articles

    16.

    Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms.

    Henry RR, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Nikoulina SE.

    J Clin Invest. 1996 Sep 1;98(5):1231-6.PMID: 8787686 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels.

    Henry RR, Ciaraldi TP, Mudaliar S, Abrams L, Nikoulina SE.

    Diabetes. 1996 Apr;45(4):400-7.PMID: 8603759 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    » See more...